Prospective Registry on Mesothelioma Peritonei Treatment (PROMPT): Study design and rationale

Tumori

Volumn 98, Issue 1, 2012, Pages 166-171

  Cao, Christopher ^a   Yan, Tristan D ^a   Morris, David L ^b   Van Der Speeten, Kurt ^c   Laurberg, Søren ^d   Glehen, Olivier ^e   Link, Karl ^f   Piso, Pompiliu ^g   Tentes, Antonios Apostolos K ^h   Deraco, Marcello ⁱ   Larsen, Stein G ^j   Kecmanovic, Dragutin ^k   Bayón, Luis G ^l   Melero, Juan T ^m   González Moreno, Santiago ⁿ   Mahteme, Haile ^o   Gertsch, Philippe ^p   Moran, Brendan ^q   Esquivel, Jesus ^r   Alexander, Richard ^s   Levine, Edward A ^t   Sugarbaker, Paul H ^u   more..

^a The Baird Institute Australia   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

^c DEPARTMENT OF CARDIOLOGY   (Belgium)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f Asklepios Tumor Center and Surgical Center   (Germany)

^g UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^h Didimotichon General Hospital   (Greece)

ⁱ NATIONAL CANCER INSTITUTE   (Italy)

^j OSLO UNIVERSITY HOSPITAL   (Norway)

^k CLINICAL CENTER OF SERBIA   (Serbia)

^l HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^m HOSPITAL TORRECÁRDENAS   (Spain)

ⁿ MD ANDERSON CANCER CENTER   (Spain)

^o UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^p UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^q NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^r ST AGNES HOSPITAL   (United States)

^s UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^t WAKE FOREST UNIVERSITY   (United States)

^u WASHINGTON CANCER INSTITUTE   (United States)

more..

Author keywords

Cytoreductive surgery; HIPEC; Peritoneal mesothelioma; Peritonectomy

Indexed keywords

ASBESTOS;

CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DIFFUSE MALIGNANT PERITONEUM MESOTHELIOMA; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HUMAN; HYPERTHERMIC THERAPY; INDUSTRIAL AREA; INFORMATION PROCESSING; LATENT PERIOD; LIFE EXPECTANCY; MESOTHELIUM; MONOTHERAPY; MORBIDITY; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PERITONEUM MESOTHELIOMA; PROGRESSION FREE SURVIVAL; PROSPECTIVE REGISTRY ON MESOTHELIOMA PERITONEI TREATMENT; SHORT SURVEY; STATISTICAL ANALYSIS; STUDY DESIGN; SURGICAL MORTALITY; SURVIVAL RATE; VALIDATION PROCESS; ARTICLE; COMPARATIVE STUDY; EUROPE; MEDICAL RECORD; MESOTHELIOMA; METHODOLOGY; MORTALITY; MULTICENTER STUDY (TOPIC); PERITONEUM TUMOR; PREOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDY; RADIOGRAPHY; REGIONAL PERFUSION; REGISTER; REPRODUCIBILITY; STANDARD; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; EUROPE; HUMANS; HYPERTHERMIA, INDUCED; MEDICAL RECORDS; MESOTHELIOMA; MULTICENTER STUDIES AS TOPIC; PERITONEAL NEOPLASMS; PREOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UNITED STATES;

EID: 84863185846     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/1053.11517     Document Type: Short Survey

References (11)

1. Robinson BW, Lake RA: Advances in malignant mesothelioma. N Engl J Med, 353: 1591-1603, 2005. (Pubitemid 41434638)
2. Marinaccio A, Binazzi A, Cauzillo G, Cavone D, De Zotti R, Ferrante P, Gennaro V, Gorini G, Menegozzo M, Mensi C, Merler E, Mirabelli D, Montanaro F, Musti M, Pannelli F, Romanelli A, Scarselli A, Tumino R: Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register. Eur J Cancer, 43: 2722-2728, 2007. (Pubitemid 350161848)
3. Rogoff EE, Hilaris BS, Huvos AG: Long-term survival in patients with malignant peritoneal mesothelioma treated with irradiation. Cancer, 32: 656-664, 1973.
4. Markman M, Kelsen D: Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma. J Cancer Res Clin Oncol, 118: 547-550, 1992.
5. Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Intengen ME: Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol, 70: 6-12, 1999. (Pubitemid 29061988)
6. Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, Salvatore A, Cabras AD, Kusamura S: Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol, 13: 229-237, 2006. (Pubitemid 43157418)
7. Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol, 27: 6237-6242, 2009.
8. Yan TD, Welch L, Black D, Sugarbaker PH: A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol, 18: 827-834, 2007. (Pubitemid 47054078)
9. Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH: A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database. Cancer 2011; 117: 1855-1863, 2011.
10. D'Agostino RB, Jr: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med, 17: 2265-2281, 1998.
11. Rosenbaum PR, Rubin DB: Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc, 79: 516-524, 1984.